老年急性髓细胞白血病患者临床治疗体会  

Elderly Patients with Acute Myeloid Leukemia Clinical Experience

作　　者：周箭[1] 陈蓉[1] 郭海鹰[1] 郑琳[1] 王小渝[1] 

机构地区：[1]成都市第三人民医院血液科,四川成都610031

出　　处：《中国伤残医学》2011年第4期19-20,共2页Chinese Journal of Trauma and Disability Medicine

摘　　要：目的:对比HA/HAG方案治疗老年急性髓细胞白血病(AHL)的临床疗效。方法:将38例AML患者随机分成UA组(18例)与HAG组(20例)分别使用以上2种方案进行化疗,比较两组的临床疗效及不良反应。结果:与HA组比较HAG组完全缓解率高,骨髓抑制时间短,不良反应发生率及早期死亡率有明显降低,总有效率7 5.0%。结论:HAG方案治疗老年急性髓细胞白血病疗效较好,毒副反应轻,结合个体化治疗方案疗效将更理想。Objective： To contrast MA / HAG in the treatment of elderly patients with acute myelogenous leukemia （AML） the clinical efficacy. Methods ： The 38 cases of AML were randomly divided intoMAgroup （18 cases） and HAG group （20 the clinical efficacy. Methods ： The 38 cases of AML were randomly divided intoMAgroup （18 cases） and HAG group （20 cases） 2 using the above programs were chemotherapy, Two groups were compared the clinical efficacy and adverse reactions. Results ： HAG MA compared with complete remission rate, Bone marrow suppression time was short, adverse reaction rates and early mortality was significantly reduced, The total effective rate 75.0%. Conclusion ： HAG in the treatment of elderly patients with acute myelogenous leukemia should be better, mild toxicity, combined with more effect ive individualized treatment plan ideal.

关 键 词：急性髓细胞白血病 老年 毒副反应 化疗方案 疗效 

分 类 号：R515[医药卫生—内科学]